ArticleJCI insight2019

Neutrophil-targeted, protease-activated pulmonary drug delivery blocks airway and systemic inflammation.

Joscelyn C Mejías et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.